30/07/2024
The Parker Institute for Cancer Immunotherapy (PICI) announced today a $125 million investment to expand its research efforts and accelerate the development of innovative cancer immunotherapies. This funding commitment, the largest since PICI’s founding in 2016, will support the institute’s coll...